Tegavivint for myeloid leukemia.
Clinical Trials – Phase 1 Myeloid Leukemia trial.
Tegavivint is a potent and selective first-in-class inhibitor of Transducin beta-like Protein One
Latam Top
Latam Top – Cohortias is the Clinical Research Organization of Latin America.
CRO partner - Cohortias continue to grow in South America. We are a local based Clinical Research Organization with one goal: expand clinical research access across Latin American countries.
methylmalonic acidemia
First-in-Human – Methylmalonic Acidemia treatment trial.
Early data from Phase 1/2 clinical trial in pediatric patients with methylmalonic acidemia showed measurable levels of a biomarker indicating site-specific gene insertion and protein expression.
Clinical Trials – Chemotherapy trial with caterpillar fungus.
An experimental cancer drug made from a molecule found in a Himalayan fungus known as “caterpillar fungus” has shown early promise as a new treatment for patients with advanced tumors in a small clinical trial.
Latam Top
CRO partner – Cohortias is the Clinical Research Organization of Latin America.
CRO partner - Cohortias continue to grow in South America. We are a local based Clinical Research Organization with one goal: expand clinical research access across Latin American countries.
new covid-19 vaccine
Clinical Trial Colombia – New Covid-19 vaccine approved.
Clinical studies of a new vaccine against Covid-19 in Colombia approved.
Diabetic retinopathy
Clinical Trials – Diabetic retinopathy therapy trial.
RGX-314 was found to be well tolerated in Cohort 1 subjects, with no drug-related serious adverse event reported.
CRO Brasil
CRO Brasil – Cohortias is the Clinical Research Organization of Latin America.
CRO Brasil - Cohortias continue to grow in South America. We are a local based Clinical Research Organization with one goal: expand clinical research access across Latin American countries.
Top CRO Mexico
Top CRO Mexico – Cohortias is the Clinical Research Organization of Latin America.
Top CRO Mexico - Cohortias continue to grow in South America. We are a local based Clinical Research Organization with one goal: expand clinical research access across Latin American countries.
Cancer therapy
Cancer therapy – Begins subject dosing in Phase 1 trial.
The trial will analyse CAM-H2’s safety, tumour uptake, retention, and antitumour activity in HER2-positive cancer patients.